Skip to content
  • About
    • About ImmixBio
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Hear From The Team
  • Technology
  • Pipeline
    • Overview
    • Publications
  • Investors & News
    • Overview
    • Press Releases
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
    • SEC Filings
    • Documents and Charters
    • Committees
    • Investor FAQ
    • Contact IR
    • Email Alerts
  • Contact
  • Subsidiary:
Immix Biopharma, Inc - Tissue-Specific Therapeutics (TSTx) Targeting Oncology & Immuno-Dysregulated Diseases
  • About
    • About ImmixBio
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Hear From The Team
  • Technology
  • Pipeline
    • Overview
    • Publications
  • Investors & News
    • Overview
    • Press Releases
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
    • SEC Filings
    • Documents and Charters
    • Committees
    • Investor FAQ
    • Contact IR
    • Email Alerts
  • Contact
  • Subsidiary:
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
    • Historical Prices
  • Financials
    • SEC Filings
  • Governance
    • Management
    • Board of Directors
    • Documents and Charters
    • Committees
  • IR Resources
    • Investor FAQ
    • Contact IR
    • Email Alerts
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
    • Historical Prices
  • Financials
    • SEC Filings
  • Governance
    • Management
    • Board of Directors
    • Documents and Charters
    • Committees
  • IR Resources
    • Investor FAQ
    • Contact IR
    • Email Alerts

© 2021

Stock Historical Lookup

11400 West Olympic Blvd, Suite 200
Los Angeles, CA 90064
T: (310) 651 8041
© 2023 Immix Biopharma, Inc.

Collaboration:

Scientific Advisory Board Members: